Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 74% ± 12% | |
lung | 18 studies | 68% ± 16% | |
intestine | 15 studies | 58% ± 25% | |
kidney | 9 studies | 66% ± 19% | |
eye | 9 studies | 46% ± 20% | |
brain | 9 studies | 40% ± 13% | |
bone marrow | 7 studies | 58% ± 25% | |
lymph node | 7 studies | 84% ± 9% | |
liver | 7 studies | 60% ± 10% | |
uterus | 6 studies | 78% ± 18% | |
pancreas | 5 studies | 80% ± 17% | |
placenta | 4 studies | 78% ± 21% | |
prostate | 4 studies | 75% ± 20% | |
breast | 4 studies | 84% ± 6% | |
ovary | 3 studies | 76% ± 19% | |
heart | 3 studies | 38% ± 16% | |
adipose | 3 studies | 37% ± 22% | |
adrenal gland | 3 studies | 69% ± 16% | |
esophagus | 3 studies | 72% ± 18% | |
skin | 3 studies | 70% ± 9% | |
thymus | 3 studies | 83% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 25403.20 | 459 / 459 | 100% | 252.91 | 1118 / 1118 |
lung | 100% | 19556.63 | 578 / 578 | 100% | 190.36 | 1155 / 1155 |
ovary | 100% | 55500.20 | 180 / 180 | 100% | 199.76 | 430 / 430 |
prostate | 100% | 20795.65 | 245 / 245 | 100% | 230.92 | 502 / 502 |
uterus | 100% | 34822.52 | 170 / 170 | 100% | 244.72 | 459 / 459 |
esophagus | 100% | 22585.94 | 1444 / 1445 | 100% | 151.69 | 183 / 183 |
thymus | 100% | 20499.06 | 653 / 653 | 100% | 235.94 | 603 / 605 |
intestine | 100% | 22060.10 | 966 / 966 | 99% | 244.09 | 524 / 527 |
pancreas | 99% | 24919.19 | 326 / 328 | 100% | 150.95 | 178 / 178 |
bladder | 100% | 24684.43 | 21 / 21 | 99% | 202.16 | 500 / 504 |
stomach | 100% | 19547.30 | 359 / 359 | 99% | 190.32 | 283 / 286 |
skin | 100% | 34419.75 | 1809 / 1809 | 99% | 260.74 | 467 / 472 |
kidney | 100% | 16917.34 | 89 / 89 | 98% | 205.88 | 885 / 901 |
adrenal gland | 100% | 19028.79 | 258 / 258 | 98% | 145.56 | 225 / 230 |
brain | 98% | 9781.59 | 2584 / 2642 | 100% | 128.60 | 705 / 705 |
liver | 93% | 8850.70 | 211 / 226 | 98% | 122.43 | 397 / 406 |
adipose | 100% | 24203.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 24147.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 350.79 | 29 / 29 |
spleen | 100% | 18724.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 229.49 | 45 / 45 |
muscle | 100% | 13394.65 | 799 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 262.23 | 79 / 80 |
heart | 94% | 11003.03 | 810 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 67% | 25574.58 | 623 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902751 | Biological process | positive regulation of cell cycle G2/M phase transition |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006281 | Biological process | DNA repair |
GO_0032071 | Biological process | regulation of endodeoxyribonuclease activity |
GO_0044387 | Biological process | negative regulation of protein kinase activity by regulation of protein phosphorylation |
GO_0034644 | Biological process | cellular response to UV |
GO_0007165 | Biological process | signal transduction |
GO_0006886 | Biological process | intracellular protein transport |
GO_0060699 | Biological process | regulation of endoribonuclease activity |
GO_0046599 | Biological process | regulation of centriole replication |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006334 | Biological process | nucleosome assembly |
GO_0007098 | Biological process | centrosome cycle |
GO_0042274 | Biological process | ribosomal small subunit biogenesis |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0042273 | Biological process | ribosomal large subunit biogenesis |
GO_0010824 | Biological process | regulation of centrosome duplication |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0000056 | Biological process | ribosomal small subunit export from nucleus |
GO_0045727 | Biological process | positive regulation of translation |
GO_0006913 | Biological process | nucleocytoplasmic transport |
GO_0010826 | Biological process | negative regulation of centrosome duplication |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0090398 | Biological process | cellular senescence |
GO_0008104 | Biological process | protein localization |
GO_1902629 | Biological process | regulation of mRNA stability involved in cellular response to UV |
GO_0060735 | Biological process | regulation of eIF2 alpha phosphorylation by dsRNA |
GO_0042255 | Biological process | ribosome assembly |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000055 | Biological process | ribosomal large subunit export from nucleus |
GO_0005730 | Cellular component | nucleolus |
GO_0001652 | Cellular component | granular component |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0016020 | Cellular component | membrane |
GO_0031616 | Cellular component | spindle pole centrosome |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0051059 | Molecular function | NF-kappaB binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0019843 | Molecular function | rRNA binding |
GO_0001046 | Molecular function | core promoter sequence-specific DNA binding |
GO_0042393 | Molecular function | histone binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0030957 | Molecular function | Tat protein binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0043024 | Molecular function | ribosomal small subunit binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0043023 | Molecular function | ribosomal large subunit binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NPM1 |
Protein name | Nucleophosmin Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin) Mutant NPM1 protein |
Synonyms | NPM hCG_1979311 |
Description | FUNCTION: Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade . In complex with MYC enhances the transcription of MYC target genes . May act as chaperonin or cotransporter in the nucleolar localization of transcription termination factor TTF1 (By similarity). . |
Accessions | ENST00000393820.2 [P06748-3] ENST00000517671.5 [P06748-1] A0A7I2V2X9 ENST00000521672.6 B1PHD4 A4ZU86 ENST00000678774.1 A0A7I2V3G5 ENST00000351986.10 [P06748-2] E5RI98 ENST00000679190.1 ENST00000677357.1 P06748 A0A7I2V5S2 ENST00000678267.1 ENST00000677907.1 ENST00000523622.1 A0A7I2V4G8 E5RGW4 A0A0S2Z491 ENST00000676589.1 ENST00000296930.10 [P06748-1] A0A0S2Z4G7 ENST00000677297.1 ENST00000676613.1 A0A7I2YQC0 ENST00000678280.1 [P06748-3] ENST00000677325.1 A0A7I2V3U2 A0A7I2V579 A0A7I2V433 Q9BTI9 A0A7I2V5J8 ENST00000679233.1 |